NVIDIA
NVDA
Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
US Stock MarketDetailed Quotes
TYPTF TRYPTAMINE THERAPEUTICS LIMITED
- 0.025
- +0.005+24.13%
15min DelayClose Dec 18 16:00 ET
31.85MMarket Cap-1.08P/E (TTM)
0.025High0.020Low29.35KVolume0.025Open0.020Pre Close730.37Turnover0.00%Turnover RatioLossP/E (Static)1.28BShares0.03952wk High8.32P/B31.85MFloat Cap0.00152wk Low--Dividend TTM1.28BShs Float0.039Historical High--Div YieldTTM24.63%Amplitude0.001Historical Low0.024Avg Price1Lot Size
TRYPTAMINE THERAPEUTICS LIMITED Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||
| Cash flow from continuing operating activities | |||||
| Cash from discontinued investing activities | |||||
| Investing cash flow | |||||
| Cash flow from continuing investing activities | 77.60%-276.64K | 31.34%-1.24M | -89.44%-1.8M | -10.59%-949.59K | -858.65K |
| Net PPE purchase and sale | 75.41%-276.64K | 30.77%-1.13M | -157.26%-1.63M | -18.39%-631.8K | ---533.65K |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---325K |
| Net investment purchase and sale | ---- | ---- | 32.12%-188.57K | ---277.79K | ---- |
| Net other investing changes | ---- | -832.99%-109.95K | 137.50%15K | ---40K | ---- |
| Cash from discontinued investing activities | |||||
| Investing cash flow | 77.60%-276.64K | 31.34%-1.24M | -89.44%-1.8M | -10.59%-949.59K | ---858.65K |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | -51.24%918.56K | -90.86%1.88M | 314.61%20.61M | -32.92%4.97M | 7.41M |
| Net issuance payments of debt | -112.37%-337.56K | 4,817.09%2.73M | ---57.86K | ---- | ---- |
| Net common stock issuance | --1.57M | ---- | 308.75%21.16M | -30.14%5.18M | --7.41M |
| Net other financing activities | 84.06%-124.34K | -57.56%-779.85K | -167.76%-494.94K | ---184.85K | ---- |
| Cash from discontinued financing activities | |||||
| Financing cash flow | -51.24%918.56K | -90.86%1.88M | 314.61%20.61M | -32.92%4.97M | --7.41M |
| Net cash flow | |||||
| Beginning cash position | -61.91%4.85M | 630.02%12.72M | -60.56%1.74M | 8,332.96%4.42M | --52.4K |
| Current changes in cash | 59.33%-3.2M | -171.76%-7.88M | 510.30%10.98M | -161.28%-2.68M | --4.37M |
| Effect of exchange rate changes | -95.37%78 | 66.34%1.69K | --1.01K | ---- | ---- |
| End cash Position | -66.11%1.64M | -61.91%4.85M | 630.02%12.72M | -60.56%1.74M | --4.42M |
| Free cash flow | 57.21%-4.13M | -2.10%-9.65M | -29.00%-9.45M | -140.82%-7.33M | ---3.04M |
| Currency Unit | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
